Zeender, E <br/><br/>
Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Oct 2004 
 - 5059-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2004-0446  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Apoptosis--drug effects<br/>Cells, Cultured<br/>Glucose--pharmacology<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Interleukin-1--metabolism<br/>Islets of Langerhans--cytology<br/>NF-kappa B--metabolism<br/>Nitric Oxide--metabolism<br/>Pioglitazone<br/>Sodium Salicylate--pharmacology<br/>Thiazolidinediones--pharmacology